The potential of closed circuit lung clearance index (LCI) to provide longitudinal clinical utility in cystic fibrosis (CF).

A. Horsley (Manchester, United Kingdom), A. Alrumuh (Stoke, United Kingdom), K. Bayfield (Manchester, United Kingdom), B. Bianco (Manchester, United Kingdom), S. Cunningham (Edinburgh, United Kingdom), A. Jones (Manchester, United Kingdom), A. Maitra (Manchester, United Kingdom), A. Pandyan (Stoke, United Kingdom), N. Rao (Manchester, United Kingdom), J. Tomlinson (Stoke, United Kingdom), F. Gilchrist (Stoke, United Kingdom), C. Fullwood (Manchester, United Kingdom)

Source: International Congress 2019 – Physiology of cystic fibrosis
Session: Physiology of cystic fibrosis
Session type: Poster Discussion
Number: 332
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Horsley (Manchester, United Kingdom), A. Alrumuh (Stoke, United Kingdom), K. Bayfield (Manchester, United Kingdom), B. Bianco (Manchester, United Kingdom), S. Cunningham (Edinburgh, United Kingdom), A. Jones (Manchester, United Kingdom), A. Maitra (Manchester, United Kingdom), A. Pandyan (Stoke, United Kingdom), N. Rao (Manchester, United Kingdom), J. Tomlinson (Stoke, United Kingdom), F. Gilchrist (Stoke, United Kingdom), C. Fullwood (Manchester, United Kingdom). The potential of closed circuit lung clearance index (LCI) to provide longitudinal clinical utility in cystic fibrosis (CF).. 332

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Variability of the lung clearance index (LCI) assessed pre and post physiotherapy in patients with cystic fibrosis (CF)
Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology
Year: 2008

Progression of lung involvement in patients with cystic fibrosis (CF), assessed by longitudinal respiratory function measurements
Source: Eur Respir J 2002; 20: Suppl. 38, 20s
Year: 2002

Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 125s
Year: 2001

Variability of multiple breath washout (MBW) assessment of functional residual capacity (FRC) in cystic fibrosis (CF) patients using an ultrasonic device
Source: Eur Respir J 2003; 22: Suppl. 45, 129s
Year: 2003

Intestinal current measurement (ICM) as a new diagnostic test for cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011

Lung clearance index (LCI) and hyperinflation in children with cystic fibrosis (CF)
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012


Improved survival at low lung function in cystic fibrosis (CF)
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009

Preschool lung clearance index (LCI) predicts adolescent lung function in cystic fibrosis (CF)
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015


Lung clearance index (LCI) and trapped gas (TG) may reflect different aspects of Cystic Fibrosis (CF) lung disease in infants
Source: Eur Respir J 2003; 22: Suppl. 45, 228s
Year: 2003

Magnetic-resonance-imaging (MRI) for assessment of regional therapy response in patients with cystic fibrosis (CF)
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009


Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010

Systematic review of lung clearance index (LCI) in non-cystic fibrosis (CF), non-primary ciliary dyskinesia (PCD) bronchiectasis (Bx)
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Monitoring small airways disease (SAD) in cystic fibrosis (CF)
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011


Potential utility of the N2 VC SBW test in cystic fibrosis (CF)
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017

Serial assessment of lung function in cystic fibrosis (CF) during the first years of life using the SF6 multiple breath washout (MBW) technique
Source: Eur Respir J 2004; 24: Suppl. 48, 156s
Year: 2004

Comparison of ventilation heterogeneity (VH) measured with multiple breath washout (MBW) imaging to whole lung MBW LCI and FEV1 in asthma and cystic fibrosis (CF)
Source: International Congress 2015 – Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles
Year: 2015


The clinical utility of lung clearance index in early cystic fibrosis lung disease is not impacted by the number of multiple-breath washout trials
Source: ERJ Open Res, 4 (1) 00094-2017; 10.1183/23120541.00094-2017
Year: 2018



Comparison of functional residual capacity (FRC) measured by plethysmography (FRCpleth) and multiple breath washout (FRCmbw) in schoolchildren with cystic fibrosis (CF).
Source: International Congress 2018 – Respiratory physiology and measurements
Year: 2018

Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients?
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017

Validation of nitrogen washout (N2-WO) for measurement of lung clearance index (LCI) and functional residual capacity (FRC) in preschoolers
Source: International Congress 2016 – What's new in paediatric respiratory physiology?
Year: 2016